172 related articles for article (PubMed ID: 32092093)
1. Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
PLoS One; 2020; 15(2):e0229264. PubMed ID: 32092093
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
3. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.
Skansing DB; Londero SC; Asschenfeldt P; Larsen SR; Godballe C
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2541-2548. PubMed ID: 28293786
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
Akaishi J; Kondo T; Sugino K; Ogimi Y; Masaki C; Hames KY; Yabuta T; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Katoh R; Ito K
World J Surg; 2019 Sep; 43(9):2235-2244. PubMed ID: 31098668
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
[TBL] [Abstract][Full Text] [Related]
6. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
Thompson LDR
Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
8. Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.
Zhang K; Wang X; Wei T; Li Z; Zhu J; Chen YW
Front Endocrinol (Lausanne); 2024; 15():1347362. PubMed ID: 38544687
[TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Prognosis of Poorly Differentiated Thyroid Carcinoma Diagnosed According to the Turin Criteria.
Huang J; Sun W; Zhang Q; Wang Z; Dong W; Zhang D; Lv C; Shao L; Zhang P; Zhang H
Endocr Pract; 2021 May; 27(5):401-407. PubMed ID: 33934750
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
Dettmer M; Schmitt A; Steinert H; Moch H; Komminoth P; Perren A
Histopathology; 2012 Jun; 60(7):1045-51. PubMed ID: 22348590
[TBL] [Abstract][Full Text] [Related]
14. Poorly differentiated thyroid carcinoma.
Xu B; Ghossein R
Semin Diagn Pathol; 2020 Sep; 37(5):243-247. PubMed ID: 32360274
[TBL] [Abstract][Full Text] [Related]
15. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.
Ibrahimpasic T; Ghossein R; Shah JP; Ganly I
Thyroid; 2019 Mar; 29(3):311-321. PubMed ID: 30747050
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in patients with poorly differentiated thyroid carcinoma.
Ibrahimpasic T; Ghossein R; Carlson DL; Nixon I; Palmer FL; Shaha AR; Patel SG; Tuttle RM; Shah JP; Ganly I
J Clin Endocrinol Metab; 2014 Apr; 99(4):1245-52. PubMed ID: 24512493
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.
Asioli S; Erickson LA; Righi A; Jin L; Volante M; Jenkins S; Papotti M; Bussolati G; Lloyd RV
Mod Pathol; 2010 Sep; 23(9):1269-78. PubMed ID: 20562850
[TBL] [Abstract][Full Text] [Related]
18. FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature.
Saglietti C; Onenerk AM; Faquin WC; Sykiotis GP; Ziadi S; Bongiovanni M
Cytopathology; 2017 Dec; 28(6):467-474. PubMed ID: 29094425
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
